Mycology (Fungal Infections)
Micafungin PSK
Registration certificate:
INN:
Micafungin
Release form:
Lyophilisate for the preparation of a solution for infusion
Therapeutic Area:
Mycology (Fungal Infections)
Pharmacotherapeutic Group:
Antifungal drugs for systemic use, other antifungal drugs for systemic use
Conditions for dispensing:
On prescription
Packaging:

Indications:

Adults (including elderly) and adolescents ≥ 16 years:

  • Treatment of invasive candidiasis
  • Treatment of esophageal candidiasis in patients requiring intravenous antifungal therapy
  • Prophylaxis of candidiasis in patients undergoing allogeneic hematopoietic stem cell transplantation or those expected to have neutropenia (neutrophil count < 500/μL) for 10 or more days

Children (including neonates) and adolescents < 16 years:

  • Treatment of invasive candidiasis
  • Prophylaxis of candidiasis in patients undergoing allogeneic hematopoietic stem cell transplantation or those expected to have neutropenia (neutrophil count < 500/μL) for 10 or more days

Included in the List of Essential Medicines

Quality control
at all stages of production